Wednesday, October 21, 2026
Saga
Description Radical Numerics is testing whether AI-designed bacteriophages can be safely and effectively used in human clinical treatment. Overview Radical Numerics used its Omnii-1 multimodal genome model to design bacteriophages for a patient with a drug-resistant E. coli infection. The company says this is the first clinical…
Tilt can alert you when its scenarios shift, or send you a recommendation when one crosses a threshold.
1 story, 1 source
Oct 20, 2026
SPY
State Street SPDR S&P 500 ETF Trust
For information only. Not investment advice.